Pfizer, Astellas Prostate Cancer Drug Promising in Late-Stage Trial

Pfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages.

Read more.

Source: Reuters